L.A. Moroz

450 total citations
19 papers, 386 citations indexed

About

L.A. Moroz is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Hematology. According to data from OpenAlex, L.A. Moroz has authored 19 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 5 papers in Hematology. Recurrent topics in L.A. Moroz's work include Protease and Inhibitor Mechanisms (8 papers), Blood properties and coagulation (7 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). L.A. Moroz is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Blood properties and coagulation (7 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). L.A. Moroz collaborates with scholars based in Canada, United States and Belarus. L.A. Moroz's co-authors include Peter D. Paré, S Inoué, R. C. Boucher, V. Ranga, James C. Hogg, Norbert Gilmore, David Langleben, J. C. Hogg, Robert Lisbona and M. McGregor and has published in prestigious journals such as Nature, Blood and Journal of Applied Physiology.

In The Last Decade

L.A. Moroz

18 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L.A. Moroz Canada	9	161	93	91	87	46	19	386
G Pignaud France	13	72 0.4×	156 1.7×	50 0.5×	22 0.3×	37 0.8×	35	418
W. R. Bell United Kingdom	5	103 0.6×	113 1.2×	20 0.2×	26 0.3×	4 0.1×	15	315
C. M. Doerschuk United States	9	174 1.1×	54 0.6×	11 0.1×	83 1.0×	49 1.1×	12	451
Klaus Pittschieler Italy	15	36 0.2×	34 0.4×	63 0.7×	34 0.4×	66 1.4×	40	772
S. Deam United Kingdom	9	60 0.4×	48 0.5×	13 0.1×	86 1.0×	81 1.8×	14	479
Catherine Tavera France	8	25 0.2×	30 0.3×	75 0.8×	60 0.7×	10 0.2×	14	369
Paul A. Cordell United Kingdom	12	197 1.2×	122 1.3×	20 0.2×	95 1.1×	6 0.1×	13	406
Takatoshi Yamamoto Japan	11	73 0.5×	28 0.3×	30 0.3×	28 0.3×	10 0.2×	21	342
Emily Barrow United States	12	87 0.5×	352 3.8×	9 0.1×	54 0.6×	18 0.4×	29	588
Kiran Dhillon Canada	6	40 0.2×	111 1.2×	21 0.2×	52 0.6×	16 0.3×	8	415

Countries citing papers authored by L.A. Moroz

Since Specialization

Citations

This map shows the geographic impact of L.A. Moroz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.A. Moroz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.A. Moroz more than expected).

Fields of papers citing papers by L.A. Moroz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.A. Moroz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.A. Moroz. The network helps show where L.A. Moroz may publish in the future.

Co-authorship network of co-authors of L.A. Moroz

This figure shows the co-authorship network connecting the top 25 collaborators of L.A. Moroz. A scholar is included among the top collaborators of L.A. Moroz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.A. Moroz. L.A. Moroz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Moroz, L.A., et al.. (2019). Dichotomy of Local Th1- and Systemic Th2/Th3-Dependent Types of Immune Response in Rheumatoid Arthritis. Bulletin of Experimental Biology and Medicine. 167(1). 69–73. 5 indexed citations

Goltzman, David, Isabel Bolivar, L.A. Moroz, & Shafaat A. Rabbani. (1992). Urokinase and the mechanism of osteoblastic metastases by prostate cancer. Fibrinolysis and Proteolysis. 6. 63–69. 4 indexed citations

Langleben, David & L.A. Moroz. (1991). Interspecies Variation in the Cellular Phase of Blood Fibrinolytic Activity. Experimental Biology and Medicine. 196(3). 270–272. 2 indexed citations

Langleben, David, L.A. Moroz, & Robert Schlesinger. (1990). Cellular-phase fibrinolysis and coronary reperfusion during acute myocardial infarction: A study in patients receiving intravenous streptokinase-methylprednisoline therapy. Thrombosis Research. 59(2). 247–258. 1 indexed citations

Moroz, L.A., et al.. (1987). Blood cells participate in the fibrinolytic response to tissue-type plasminogen activator. Blood. 70(2). 564–567. 7 indexed citations

Moroz, L.A., et al.. (1986). Aspirin and venous occlusion: Effects on blood fibrinolytic activity and tissue-type plasminogen activator levels. Thrombosis Research. 42(1). 73–82. 15 indexed citations

Langleben, David, L.A. Moroz, M. McGregor, & Robert Lisbona. (1985). Decreased half-life of fibrinogen in primary pulmonary hypertension. Thrombosis Research. 40(4). 577–580. 11 indexed citations

Langleben, David & L.A. Moroz. (1985). Participation of blood cells in exercise-induced fibrinolysis. Thrombosis Research. 39(6). 733–740. 12 indexed citations

Moroz, L.A.. (1981). Mini-plasminogen: a mechanism for leukocyte modulation of plasminogen activation by urokinase. Blood. 58(1). 97–104. 50 indexed citations

10.

Boucher, R. C., V. Ranga, Peter D. Paré, et al.. (1978). Effect of histamine and methacholine on guinea pig tracheal permeability to HRP. Journal of Applied Physiology. 45(6). 939–948. 85 indexed citations

11.

Paré, Peter D., et al.. (1977). Airway mucosal permeability in the Ascaris suum-sensitive rhesus monkey. Journal of Allergy and Clinical Immunology. 60(2). 134–140. 45 indexed citations

12.

Moroz, L.A. & Norbert Gilmore. (1976). Inhibition of plasmin-mediated fibrinolysis by vitamin E. Nature. 259(5540). 235–237. 8 indexed citations

13.

Moroz, L.A., et al.. (1976). Mechanisms involved in enhancement of plasma fibrinolytic activity by chloroform. Blood. 48(5). 777–790. 5 indexed citations

14.

Joubert, Lynette, Kathryn J. Ascah, L.A. Moroz, & J. C. Hogg. (1976). Acute hypersensitivity pneumonitis in the rabbit. I. An animal model with horseradish peroxidase as antigen.. PubMed. 113(4). 503–13.

15.

Moroz, L.A., et al.. (1976). Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system. Blood. 48(4). 531–545. 34 indexed citations

16.

Moroz, L.A., et al.. (1975). Mixed IgG-IgA Cryoglobulinemia in Human Serum Sickness. International Archives of Allergy and Immunology. 48(6). 756–763. 8 indexed citations

17.

Moroz, L.A., et al.. (1975). A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin. Blood. 46(4). 543–553. 76 indexed citations

18.

Moroz, L.A., et al.. (1973). Cell Fractionation on Affinity Columns. International Archives of Allergy and Immunology. 44(5). 657–666. 5 indexed citations

19.

Moroz, L.A., et al.. (1973). Normal human IgG with antibody activity for keyhole limpet haemocyanin.. PubMed. 25(3). 441–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact